tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

China SXT Pharmaceuticals Inc

SXTC
Add to Watchlist
0.061USD
-0.012-16.42%
Close 07-31 16:00（ET）Quotes delayed by 15 min
58.54KMarket Cap
LossP/E TTM

China SXT Pharmaceuticals Inc

0.061
-0.012-16.42%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

SXTC Financials

See China SXT Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

China SXT Pharmaceuticals Inc Earnings Date

Latest Release
Jul 1, 2026
EPS / Forecast
-9.13/--
Revenue / Forecast
1.14M/--
See Upcoming Earnings >>
Period
FY2026 Earnings
Revenue(YoY)
1.14M
-34.63%
EPS(YoY)
-9.13
97.38%
Analyst Rating
--
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025H2
FY2025H1
FY2024H2
FY2024H1
FY2023H2
FY2023H1
FY2022H2
FY2022H1
FY2021H2
FY2021H1
FY2020H2
FY2020H1
FY2019H2
FY2019H1
FY2018Q4
FY2018Q3
FY2017Q4
Financial Indicators
EPS
---1.02
---1.99
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
----
-11.72%829.49K
29.54%988.91K
-22.24%939.58K
-51.52%763.39K
17.58%1.21M
71.70%1.57M
-73.38%1.03M
-52.90%917.07K
20.07%3.86M
-37.07%1.95M
-17.93%3.22M
--3.09M
--3.92M
24.40%1.43M
----
--1.15M
Net Profit
----
91.72%-802.57K
248.59%6.60M
-548.74%-9.70M
-67.92%-4.44M
51.66%-1.49M
35.97%-2.64M
-323.84%-3.09M
47.99%-4.13M
158.83%1.38M
-1559.04%-7.94M
-335.98%-2.35M
--544.18K
--995.05K
-51.48%181.87K
----
--374.81K
Net Margin
---274.42%
---96.75%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
--25.53%
--16.25%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Debt to assets ratio
--3.73%
--7.14%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income Statement
Revenue
----
-11.72%829.49K
29.54%988.91K
-22.24%939.58K
-51.52%763.39K
17.58%1.21M
71.70%1.57M
-73.38%1.03M
-52.90%917.07K
20.07%3.86M
-37.07%1.95M
-17.93%3.22M
--3.09M
--3.92M
24.40%1.43M
----
--1.15M
Operating profit
----
93.17%-638.27K
253.33%6.83M
-712.64%-9.35M
-93.94%-4.46M
60.21%-1.15M
31.62%-2.30M
-348.45%-2.89M
-199.98%-3.36M
627.20%1.16M
-353.16%-1.12M
-116.64%-220.75K
--442.56K
--1.33M
-40.89%300.05K
----
--507.65K
Net Profit
----
91.72%-802.57K
248.59%6.60M
-548.74%-9.70M
-67.92%-4.44M
51.66%-1.49M
35.97%-2.64M
-323.84%-3.09M
47.99%-4.13M
158.83%1.38M
-1559.04%-7.94M
-335.98%-2.35M
--544.18K
--995.05K
-51.48%181.87K
----
--374.81K
Balance Sheet
Current assets
49.62%21.30M
62.93%21.99M
-27.09%14.23M
9.19%13.50M
-13.05%19.52M
5.99%12.36M
-3.36%22.45M
-47.14%11.66M
18.32%23.23M
25.75%22.06M
25.97%19.64M
167.87%17.54M
--15.59M
--6.55M
--6.10M
--7.52M
----
Total current liabilities
-32.46%6.01M
70.26%15.66M
-38.59%8.90M
26.17%9.20M
-15.33%14.50M
-17.87%7.29M
-7.85%17.12M
61.24%8.88M
51.50%18.58M
-48.84%5.51M
94.01%12.26M
169.66%10.76M
--6.32M
--3.99M
--4.37M
--5.12M
----
Total assets
-6.33%21.66M
112.49%31.00M
-21.75%23.13M
-34.23%14.59M
-11.90%29.55M
-2.16%22.18M
-2.90%33.55M
-5.71%22.67M
59.19%34.55M
4.33%24.04M
24.22%21.70M
189.84%23.05M
--17.47M
--7.95M
--7.66M
--8.12M
----
Total liabilities
-32.33%6.22M
67.82%15.96M
-38.12%9.20M
30.44%9.51M
-13.19%14.86M
-17.87%7.29M
-7.88%17.12M
60.80%8.88M
51.10%18.59M
-52.55%5.52M
93.32%12.30M
191.54%11.64M
--6.36M
--3.99M
--4.37M
--5.12M
----
Total equity
10.83%15.44M
196.18%15.03M
-5.18%13.93M
-65.91%5.08M
-10.55%14.69M
7.96%14.89M
2.90%16.42M
-25.54%13.79M
69.78%15.96M
62.34%18.52M
-15.36%9.40M
188.13%11.41M
--11.11M
--3.96M
--3.29M
--3.00M
----
Cash Flow Statement
Net operating income
----
-134.17%-1.36M
-387.91%-1.35M
-5.54%-579.57K
-19.34%468.37K
-75.80%-549.13K
159.07%580.64K
6.34%-312.35K
-133.23%-983.05K
83.52%-333.51K
--2.96M
---2.02M
----
----
1644.05%2.13M
----
--122.36K
Net investment
----
106.45%40.54K
113.14%6.78K
-50.04%19.64K
-100.56%-51.61K
100.42%39.31K
208.33%9.26M
-439.75%-9.30M
-96579.50%-8.54M
149.89%2.74M
---8.84K
---5.49M
----
----
-1644.58%-1.62M
----
---93.05K
Net financing
----
262.21%7.24M
-86.89%1.84M
59.69%-4.46M
154.53%14.01M
-183.14%-11.07M
-54.64%5.50M
-1524.22%-3.91M
412.02%12.13M
-96.03%274.50K
---3.89M
--6.91M
----
----
-1141.37%-4.10K
----
--394.00

FAQs

What is the total revenue of China SXT Pharmaceuticals Inc?

According to China SXT Pharmaceuticals Inc's FY2026 earnings report, its total revenue reached 1.14M, with a year-on-year change of 1.74M.

What are the current assets of China SXT Pharmaceuticals Inc?

According to China SXT Pharmaceuticals Inc's FY2026 earnings report, its current assets were 34.51M, with a year-on-year change of 62.04.

What are the total assets of China SXT Pharmaceuticals Inc?

According to China SXT Pharmaceuticals Inc's FY2026 earnings report, its total assets of China SXT Pharmaceuticals Inc were 34.75M, with a year-on-year change of 60.43.

What are the total liabilities of China SXT Pharmaceuticals Inc?

According to China SXT Pharmaceuticals Inc's FY2026 earnings report, its total liabilities of China SXT Pharmaceuticals Inc were 5.05M, with a year-on-year change of -18.90.

What is the total equity of China SXT Pharmaceuticals Inc?

According to China SXT Pharmaceuticals Inc's FY2026 earnings report, its total equity of China SXT Pharmaceuticals Inc was 29.71M, with a year-on-year change of 92.41.

What is the net operating income of China SXT Pharmaceuticals Inc?

According to China SXT Pharmaceuticals Inc's FY2026 earnings report, its net operating income of China SXT Pharmaceuticals Inc was -7.12M, with a year-on-year change of -325.40.

What is the net investment of China SXT Pharmaceuticals Inc?

According to China SXT Pharmaceuticals Inc's FY2026 earnings report, its net investment of China SXT Pharmaceuticals Inc was -1.25M, with a year-on-year change of -2069.46.

What is the net financing of China SXT Pharmaceuticals Inc?

According to China SXT Pharmaceuticals Inc's FY2026 earnings report, its net financing of China SXT Pharmaceuticals Inc was 14.43M, with a year-on-year change of 71.84.

What is the Earnings Per Share (EPS) of China SXT Pharmaceuticals Inc?

According to China SXT Pharmaceuticals Inc's FY2026 earnings report, its Earnings Per Share (EPS) was -9.13, with a year-on-year change of 97.38.

What is the net income of China SXT Pharmaceuticals Inc?

According to China SXT Pharmaceuticals Inc's FY2026 earnings report, its net income was -6.21M, with a year-on-year change of -87.83.

What is the net margin of China SXT Pharmaceuticals Inc?

According to China SXT Pharmaceuticals Inc's FY2026 earnings report, its net profit margin was -545.24, with a year-on-year change of -187.32.

What is the gross margin of China SXT Pharmaceuticals Inc?

According to China SXT Pharmaceuticals Inc's FY2026 earnings report, its gross margin was 21.85, with a year-on-year change of 3.54.

What is the debt-to-asset ratio of China SXT Pharmaceuticals Inc?

According to China SXT Pharmaceuticals Inc's FY2026 earnings report, its debt-to-asset ratio was 2.88, with a year-on-year change of -22.82.

What is the Return on Equity (ROE) of China SXT Pharmaceuticals Inc?

According to China SXT Pharmaceuticals Inc's FY2026 earnings report, its Return on Equity (ROE) was -27.49, with a year-on-year change of -22.19.

What is the Return on Assets (ROA) of China SXT Pharmaceuticals Inc?

According to China SXT Pharmaceuticals Inc's FY2026 earnings report, its Return on Assets (ROA) was -22.00, with a year-on-year change of -49.12.

What is the operating profit of China SXT Pharmaceuticals Inc?

According to China SXT Pharmaceuticals Inc's FY2026 earnings report, its operating profit was -7.12M, with a year-on-year change of -325.40.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy